Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials
Open Access
- 9 March 2019
- journal article
- research article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 21 (7) , 1745-1751
Abstract
Cardiovascular risk reduction with liraglutide and semaglutide in patients with type 2 diabetes was demonstrated in the LEADER ( ClinicalTrials.gov : NCT01179048) and SUSTAIN 6 ( ClinicalTrials.gov : NCT01720446) cardiovascular outcome trials. This post hoc analysis assessed the impact of diabetes duration (P ‐interaction was not significant for all endpoints analysed).Keywords
Funding Information
- Novo Nordisk
This publication has 13 references indexed in Scilit:
- Liraglutide Reduces Cardiovascular Events and Mortality in Type 2 Diabetes Mellitus Independently of Baseline Low-Density Lipoprotein Cholesterol Levels and Statin UseCirculation, 2018
- Effect of diabetes duration and glycaemic control on 14-year cause-specific mortality in Mexican adults: a blood-based prospective cohort studyThe Lancet Diabetes & Endocrinology, 2018
- Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular DiseaseCirculation, 2018
- Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 InhibitorsCirculation, 2017
- Liraglutide and Cardiovascular Outcomes in Type 2 DiabetesNew England Journal of Medicine, 2016
- The Cardiovascular Biology of Glucagon-like Peptide-1Cell Metabolism, 2016
- Impact of diabetes duration on the extent and severity of coronary atheroma burden and long-term clinical outcome in asymptomatic type 2 diabetic patients: evaluation by Coronary CT angiographyEuropean Heart Journal - Cardiovascular Imaging, 2015
- Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetesDiabetologia, 2014
- Impact of Diabetes on Cardiovascular Disease Risk and All-Cause Mortality in Older MenArchives of internal medicine (1960), 2011
- The Significant Effect of Diabetes Duration on Coronary Heart Disease MortalityDiabetes Care, 2004